Q38L21 (Q38L21_HUMAN) Homo sapiens (Human)
C-C chemokine receptor type 5 UniProtKBInterProInteractive Modelling
352 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P51681
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structural basis of coreceptor recognition by HIV-1 envelope spike |
Heteromer P01730; P51681; Q70145; | 6×NAG; 2×NAG; 1×NAG; 7×NAG; 1×A2G; | ||||
| Assess | ||||||
| Structural basis of coreceptor recognition by HIV-1 envelope spike |
Heteromer P01730; P51681; Q70145; | 6×NAG; 2×NAG; 1×NAG; 7×NAG; 1×BMA; 1×A2G; | ||||
| Assess | ||||||
| Cryo-EM structure of the chemokine receptor CCR5 in complex with RANTES and Gi |
Heteromer P13501; P51681; P59768; P62873; P63096; | |||||
| Assess | ||||||
| Cryo-EM structure of the chemokine receptor CCR5 in complex with MIP-1a and Gi |
Heteromer P10147; P51681; P59768; P62873; P63096; | |||||
| Assess | ||||||
| Crystal Structure of CC Chemokine Receptor 5 (CCR5) in complex with high potency HIV entry inhibito… |
Heteromer P00268; P13501; P51681; | 1×ZN; 6×OLC; 2×OLA; | ||||
| Assess | ||||||
| Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist |
Heteromer P02698; P13501; P51681; P62871; P63096; | |||||
| Assess | ||||||
| Cryo-EM structure of the apo chemokine receptor CCR5 in complex with Gi |
Heteromer P51681; P59768; P62873; P63096; | |||||
| Assess | ||||||
| NMR solution structure of monomeric CCL5 in complex with a doubly-sulfated N-terminal segment of CC… |
Heteromer P13501; P51681; | |||||
| Assess | ||||||
| Crystal structure of the scFv antibody 4B08 with epitope peptide (mutation T6A) |
Heteromer P01630; P51681; | 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of the scFv antibody 4B08 with epitope peptide |
Heteromer P01630; P51681; | 4×SO4; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the scFv antibody 4B08 with sulfated epitope peptide |
Heteromer P51681; | 2×SO4; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the scFv antibody 4B08 with epitope peptide (mutation N3A) |
Heteromer P01630; P51681; | 5×SO4; | ||||
| Assess | ||||||
| Structure of arrestin2 in complex with 6P CCR5 phosphopeptide and Fab30 |
Heteromer P49407; P51681; | |||||
| Assess | ||||||
| X-ray crystallography study of RoAb13 which binds to PIYDIN, a part of the CCR5 N terminal domain |
Heteromer P51681; | |||||
| Assess | ||||||
| X-ray crystallographic study of PIYDIN, which contains the truncation determinants of binding PI an… |
Heteromer P51681; | |||||
| Assess | ||||||
| Structure of arrestin2 in complex with 4P CCR5 phosphopeptide and Fab30 |
Heteromer P49407; P51681; | |||||
| Assess | ||||||
| Crystal structure of the human chemokine receptor CCR5 in complex with MIP-1a | monomer | 1×ZN; | ||||
| Assess | ||||||
| Crystal Structure of the CCR5 Chemokine Receptor | monomer | 1×MRV; 1×ZN; 6×OLC; | ||||
| Assess | ||||||
| The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 34 | monomer | 1×ZN; 1×OLC; 1×A4X; | ||||
| Assess | ||||||
| The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 21 | monomer | 1×ZN; 1×NO3; 1×A4R; | ||||
| Assess | ||||||
| NMR Structure of LC4 transmembrane segment of CCR5 | monomer | |||||
| Assess | ||||||
| The 27-residue N-terminus CCR5-peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide | monomer | |||||
| Assess | ||||||
| CCR5-ECL2 helical structure, residues Q186-T195 | monomer | |||||
| Assess | ||||||
| CCR5 Nt(7-15) | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5uiw.1.A | monomer | 0.74 | 6×OLC; 1×OLA; | 97.99 | ||
| Assess | ||||||